UTime Limited - SIC # 3684 -

Ticker Exchange SIC # Website Latest Ticker
WTO Nasdaq 3684 www.utimemobile.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for UTime Limited

UTime Limited Announces 1-For-10 Reverse Share Split - Mar 26th, 2025 1:00 pm
UTime First Half 2025 Earnings: CN¥192 loss per share (vs CN¥19.15 loss in 1H 2024) - Jan 20th, 2025 6:36 pm
UTime Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency - Oct 17th, 2024 8:05 pm
UTime Limited Announces Pricing of $5 Million Registered Direct Offering - Sep 13th, 2024 1:00 pm
UTime Limited Announces 1-For-25 Reverse Share Split - Sep 9th, 2024 3:00 pm
Remarkable Announcement on Significant Fluctuation of the UTime's Share Price - Aug 29th, 2024 4:33 pm
UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines - Aug 28th, 2024 3:06 pm
UTime Limited Partners with Dr. Ehud Baron to Pioneer AI-Driven Health Solutions - Aug 19th, 2024 1:00 pm
UTime Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule - Aug 13th, 2024 8:05 pm